202 related articles for article (PubMed ID: 25665711)
1. Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study.
Meyer T; Herrrmann-Lingen C; Chavanon ML; Nolte K; Pasedach CA; Binder L; Pieske B; Hasenfuss G; Wachter R; Edelmann F
Clin Res Cardiol; 2015 Jul; 104(7):574-81. PubMed ID: 25665711
[TBL] [Abstract][Full Text] [Related]
2. Plasma mid-regional pro-adrenomedullin levels are inversely associated with anxiety but unrelated to depression: Results from the observational DIAST-CHF study in patients with cardiovascular risk factors.
Meyer T; Herrmann-Lingen C; Chavanon ML; Pieske B; Wachter R; Edelmann F
Psychoneuroendocrinology; 2015 Dec; 62():227-32. PubMed ID: 26342564
[TBL] [Abstract][Full Text] [Related]
3. Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study.
Sadlonova M; Meyer T; Binder L; Wachter R; Edelmann F; Herrmann-Lingen C
Psychoneuroendocrinology; 2019 Mar; 101():272-277. PubMed ID: 30594111
[TBL] [Abstract][Full Text] [Related]
4. Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study.
Meyer T; Chavanon ML; Herrrmann-Lingen C; Roggenthien M; Nolte K; Pieske B; Wachter R; Edelmann F
PLoS One; 2015; 10(8):e0136739. PubMed ID: 26322793
[TBL] [Abstract][Full Text] [Related]
5. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
6. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
[TBL] [Abstract][Full Text] [Related]
7. The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
Kube J; Ebner N; Jankowska EA; Rozentryt P; Cicoira M; Filippatos GS; Ponikowski P; Doehner W; Anker SD; von Haehling S
Int J Cardiol; 2016 Sep; 219():84-91. PubMed ID: 27288971
[TBL] [Abstract][Full Text] [Related]
8. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
10. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
11. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
Rubattu S; Barbato A; Marchitti S; Iacone R; Di Castro S; Evangelista A; Stanzione R; Ippolito R; Sciarretta S; Palmieri L; Volpe M; Strazzullo P;
J Hypertens; 2010 Aug; 28(8):1638-45. PubMed ID: 20453667
[TBL] [Abstract][Full Text] [Related]
12. Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides.
Eggers KM; Venge P; Lind L
Clin Chim Acta; 2013 Apr; 419():62-6. PubMed ID: 23415698
[TBL] [Abstract][Full Text] [Related]
13. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
14. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
[TBL] [Abstract][Full Text] [Related]
15. High plasma levels of N-terminal pro-atrial natriuretic peptide associated with low anxiety in severe heart failure.
Herrmann-Lingen C; Binder L; Klinge M; Sander J; Schenker W; Beyermann B; von Lewinski D; Pieske B
Psychosom Med; 2003; 65(4):517-22. PubMed ID: 12883099
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
Porcel JM; Bielsa S; Morales-Rull JL; Civit C; Cao G; Light RW; Esquerda A
Respirology; 2013 Apr; 18(3):540-5. PubMed ID: 23278975
[TBL] [Abstract][Full Text] [Related]
17. [Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
Zhao XY; Yang YJ; Zhang J; Kang LM; Wei BQ; Gao XJ; Lü R; Zhang CL
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):486-90. PubMed ID: 19927626
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
19. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
Theilade S; Hansen TW; Goetze JP; Rossing P
Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
